Oncolytics After 2017 Refresh: New CEO Makes New Year Resolutions

 
• By Lucie Ellis-Taitt
  
2018
Oncolytics prepares to launch Phase III trial in 2018 for lead drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business